Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway

被引:45
作者
Hu, Jie [1 ]
Hong, Wei [2 ]
Yao, Kan-Nan [2 ]
Zhu, Xiao-Hong [1 ]
Chen, Zhi-Yun [2 ]
Ye, Lei [1 ]
机构
[1] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Infect Dis, 54 Youdian Rd, Hangzhou 310006, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Cent Lab 2, Hangzhou 310006, Zhejiang, Peoples R China
关键词
Ursodeoxycholic acid; Hepatic lipid metabolism; AKT/mTOR/SREBP-1; Hepatic steatosis; NONALCOHOLIC FATTY LIVER; FARNESOID X RECEPTOR; BILE-ACIDS; OXIDATIVE STRESS; LIPOGENESIS; DISEASE; TRANSCRIPTION; SREBP-1; ACCUMULATION; CHOLESTEROL;
D O I
10.3748/wjg.v25.i12.1492
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease, can progress into nonalcoholic steatohepatitis (NASH), cirrhosis, and even hepatocellular carcinoma. Bile acids such as ursodeoxycholic acid (UDCA) play an essential role in the pathogenesis of NAFLD by regulating the level of sterol regulatory element-binding protein (SREBP) 1c, but the underlying regulatory mechanism remains elusive. Increased evidence indicates that the AKT/mTOR/SREBP-1 signaling pathway is a key pathway to regulate hepatic cellular lipid metabolism. UDCA may regulate the AKT/mTOR/SREBP-1 signaling pathway to ameliorate hepatic lipid metabolism. AIM To investigate the functional mechanism of UDCA in an oleic acid (OA)-induced cellular model of NAFLD. METHODS The cellular model of NAFLD was established using OA and treated with UDCA. First, the best concentration of UDCA was selected. For the best time-dependent assay, cells were stimulated with OA only or co-treated with OA and 2 mmol/L UDCA for 24 h, 48 h, and 72 h. Oil red O staining was used to observe the accumulation of intracellular lipids, while the intracellular contents of triglyceride, alanine aminotransferase (ALT), gamma-glutamyl transpeptidase (GGT), and aspartate aminotransferase (AST) were detected by enzymatic methods. Meanwhile, the expression levels of AKT/mTOR/SREBP-1 signaling pathway-related proteins were detected by real-time PCR and Western blot. RESULTS In the NAFLD cell model established with LO2 cells induced using OA, lipid accumulation was obvious. UDCA significantly inhibited lipid accumulation at different concentrations (especially 2 mmol/L) and decreased cell growth ability at different time points. The biochemical parameters like ALT, AST, and GGT were significant improved by UDCA. UDCA treatment vividly repressed the activation of AKT, mTOR, and CRTC2 and the expression of nSREBP-1 in LO2 cells induced with OA. CONCLUSION Our findings demonstrate the effect of UDCA in improving NAFLD. UDCA attenuates OA-induced hepatic steatosis mainly by regulation of AKT/mTOR/SREBP-1 signal transduction.
引用
收藏
页码:1492 / 1501
页数:10
相关论文
共 39 条
  • [1] Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats
    Ali, Mahmoud Hussein Hassan
    Messiha, Basim Anwar Shehata
    Abdel-Latif, Hekma Abdel-Tawab
    [J]. PHARMACEUTICAL BIOLOGY, 2016, 54 (07) : 1198 - 1208
  • [2] Metabolic syndrome and non-alcoholic fatty liver disease
    Almeda-Valdes, Paloma
    Cuevas-Ramos, Daniel
    Aguilar-Salinas, Carlos Alberto
    [J]. ANNALS OF HEPATOLOGY, 2009, 8 : S18 - S24
  • [3] Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives
    Arab, Juan P.
    Karpen, Saul J.
    Dawson, Paul A.
    Arrese, Marco
    Trauner, Michael
    [J]. HEPATOLOGY, 2017, 65 (01) : 350 - 362
  • [4] Ursodeoxycholic acid induces glutathione synthesis through activation of PI3K/Akt pathway in HepG2 cells
    Arisawa, Sakiko
    Ishida, Kumiki
    Kameyama, Natsumi
    Ueyama, Jun
    Hattori, Ai
    Tatsumi, Yasuaki
    Hayashi, Hisao
    Yano, Motoyoshi
    Hayashi, Kazuhiko
    Katano, Yoshiaki
    Goto, Hidemi
    Takagi, Kenji
    Wakusawa, Shinya
    [J]. BIOCHEMICAL PHARMACOLOGY, 2009, 77 (05) : 858 - 866
  • [5] Connecting mTORC1 signaling to SREBP-1 activation
    Bakan, Inan
    Laplante, Mathieu
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2012, 23 (03) : 226 - 234
  • [6] OXIDATIVE STRESS, MITOCHONDRIA DAMAGE AND MATRIX METALLOPROTEASE ACTIVATION IN THE PATHOGENESIS OF NAFLD
    Berardo, C.
    Palladini, G.
    Di Pasqua, L. G.
    Rizzo, V.
    Perlini, S.
    Richelmi, P.
    Vairetti, M.
    Ferrigno, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2015, 47 : E60 - E61
  • [7] The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
    Brown, MS
    Goldstein, JL
    [J]. CELL, 1997, 89 (03) : 331 - 340
  • [8] Bile acids and nonalcoholic fatty liver disease: An intriguing relationship
    Carulli, Lucia
    Gabbi, Chiara
    Bertolotti, Marco
    [J]. HEPATOLOGY, 2016, 63 (05) : 1739 - 1740
  • [9] The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Chow, Monica D.
    Lee, Yi-Horng
    Guo, Grace L.
    [J]. MOLECULAR ASPECTS OF MEDICINE, 2017, 56 : 34 - 44
  • [10] SREBP transcription factors:: master regulators of lipid homeostasis
    Eberlé, D
    Hegarty, B
    Bossard, P
    Ferré, P
    Foufelle, F
    [J]. BIOCHIMIE, 2004, 86 (11) : 839 - 848